跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,577 条关于
“Hyundai ADM Bio”
全部
10,577
临床试验
5,977
药物
1,764
机构
312
资讯
2,524
去年
Hyundai ADM Bio Pivots Strategy to Focus on Immunotherapy Combinations for Cancer Treatment
去年
Penetrium Shows Promising Anti-Metastatic Effects in Triple-Negative Breast Cancer Preclinical Study
2年前
UCSD and Hyundai Bio to Evaluate Xafty for Long COVID Treatment
去年
Enibarcimab Shows Promising Results in Biomarker-Guided Septic Shock Treatment
上个月
Hyundai Hope on Wheels Funds Two Pediatric AML Research Programs Targeting Relapse and Treatment Resistance
2年前
Hyundai Bioscience Initiates Phase 3 Trial of Xafty for High-Risk COVID-19 Patients
3个月前
Hyundai Bioscience Offers Free XAFTY® Supply and Trial Funding to WHO for Ebola Emergency Response
去年
Korean Biotech Hyundai Bioscience Reports Positive Phase II Results for Oral COVID-19 Treatment CP-COV03
上个月
Penitrium Targets Tumor 'Pseudo-Resistance' as First Prostate Cancer Patient Dosed and FDA Clears US Phase 2a
去年
ADM's PRIOME MH Postbiotic Shows Metabolic Benefits in Canine Clinical Trial
第 1 页,共 253 页
上一页
下一页